Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1500 | Ribociclib | 0.0316227766017 | 0.2054 | -0.13644 |
| HCC1500 | Senexin B | 0.00316227766017 | 1.2001 | -0.13640 |
| HCC1500 | BMS-265246 | 0.1 | -0.5358 | -0.13527 |
| HCC1500 | Alvocidib | 0.01 | -0.3453 | -0.13468 |
| HCC1500 | GSK2334470 | 10.0 | -0.4701 | -0.13446 |
| HCC1500 | Ribociclib | 0.1 | 0.0946 | -0.13410 |
| HCC1500 | GSK2334470 | 0.001 | 2.1613 | -0.13323 |
| HCC1500 | RO-3306 | 0.00316227766017 | -0.2821 | -0.13308 |
| HCC1500 | MK 1775 | 0.1 | -0.8273 | -0.13296 |
| HCC1500 | SHP099 | 0.01 | -0.3965 | -0.13270 |
| HCC1500 | Ribociclib | 0.00316227766017 | 0.6982 | -0.13261 |
| HCC1500 | Alvocidib | 0.316227766017 | -0.1495 | -0.13252 |
| HCC1500 | Senexin B | 0.00316227766017 | 0.0483 | -0.13215 |
| HCC1500 | Alvocidib | 0.1 | 0.5333 | -0.13181 |
| HCC1500 | Ribociclib | 1.0 | -0.2227 | -0.12938 |
| HCC1500 | Ribociclib | 10.0 | 1.8249 | -0.12891 |
| HCC1500 | Alvocidib | 0.316227766017 | -0.4701 | -0.12754 |
| HCC1500 | GSK2334470 | 0.01 | -0.2314 | -0.12724 |
| HCC1500 | AZD5363 | 1.0 | 0.0036 | -0.12658 |
| HCC1500 | Ribociclib | 0.316227766017 | -0.1590 | -0.12579 |
| HCC1500 | Rucaparib | 0.0316227766017 | 0.0712 | -0.12378 |
| HCC1500 | THZ531 | 0.1 | -0.7006 | -0.12342 |
| HCC1500 | RO-3306 | 0.316227766017 | 0.6304 | -0.12241 |
| HCC1500 | THZ1 | 0.001 | -0.2487 | -0.12205 |
| HCC1500 | BMS-265246 | 0.00316227766017 | 0.5020 | -0.12117 |